Bionano Genomics (BNGO) Short-term Investments (2021 - 2026)

Bionano Genomics (BNGO) has 6 years of Short-term Investments data on file, last reported at $10.3 million in Q1 2026.

• For the quarter ending Q1 2026, Short-term Investments fell 29.71% year-over-year to $10.3 million; the trailing twelve-month figure through Mar 2026 stood at $10.3 million (down 29.71% YoY), and the FY2025 full-year result was $10.3 million, down 6.36% from the prior year.
• Short-term Investments steadied at $10.3 million in Q1 2026, from $10.3 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $192.4 million in Q1 2022 to a low of $3.2 million in Q3 2024.
• A 5-year average of $52.5 million and a median of $16.6 million in 2025 frame the typical range for Short-term Investments.
• Across the five-year window, Short-term Investments sank 89.1% in 2024 and surged 485.44% in 2025, its largest moves.
• Tracing BNGO's Short-term Investments over 5 years: stood at $152.0 million in 2022, then tumbled by 67.88% to $48.8 million in 2023, then slumped by 77.47% to $11.0 million in 2024, then declined by 6.36% to $10.3 million in 2025, then dropped by 0.33% to $10.3 million in 2026.
• Business Quant data shows BNGO's Short-term Investments at $10.3 million in Q1 2026, $10.3 million in Q4 2025, and $18.5 million in Q3 2025.